High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia

Clinical and Translational Oncology

Volumn 17, Issue 5, 2015, Pages 358-364

  Lin, X ^a   Wang, Z ^b   Zhang, R ^c   Feng, W ^c  

^a Huai'an Maternal and Child Health Care Center   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

MicroRNA 335; Pediatric acute myeloid leukemia; Prognosis; Real time quantitative PCR; Serum

Indexed keywords

MICRORNA; MIRN335 MICRORNA, HUMAN;

ADOLESCENT; BLOOD; BONE MARROW; CASE CONTROL STUDY; CHILD; CLASSIFICATION; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; GENETICS; HUMAN; KARYOTYPE; LEUKEMIA, MYELOID, ACUTE; MALE; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; PREDICTIVE VALUE; PRESCHOOL CHILD; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; UPREGULATION;

ADOLESCENT; BONE MARROW; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KARYOTYPE; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; UP-REGULATION;

EID: 84939880992     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-014-1237-z     Document Type: Article

References (23)

1. Russell NH. Biology of acute leukaemia. Lancet. 1997;349:118–22.
2. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730–7.
3. Estey EH. Acute myeloid leukemia: 2013 update on risk-stratification and management. Am J Hematol. 2013;88:318–27.
4. Ganetsky A. The role of decitabine for the treatment of acute myeloid leukemia. Ann Pharmacother. 2012;46:1511–7.
5. Puumala SE, Ross JA, Aplenc R, Spector LG. Epidemiology of childhood acute myeloid leukemia. Pediatr Blood Cancer. 2013;60:728–33.
6. Danen-van Oorschot AA, Kuipers JE. Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Pediatr Blood Cancer. 2012;58:715–21.
7. Liu X, Liu L, Xu Q. MicroRNA as a novel drug target for cancer therapy. Expert Opin Biol Ther. 2012;12:573–80.
8. Esteller M. Non coding RNAs in human disease. Nat Rev Genet. 2011;12:861–74.
9. van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11:644–56.
10. Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012;6:590–610.
11. Nana-Sinkam SP, Croce CM. Clinical applications for microRNAs in cancer. Clin Pharmacol Ther. 2013;93:98–104.
12. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.
13. Medina PP, Slack FJ. microRNAs and cancer: an overview. Cell Cycle. 2008;7:2485–92.
14. Zhu C, Wang Y, Kuai W. Prognostic value of miR-29a expression in pediatric acute myeloid leukemia. Clin Biochem. 2013;46:49–53.
15. Zhi F, Cao X, Xie X. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. PLoS One. 2013;8:e56718.
16. Croce CM. MicroRNA dysregulation in acute myeloid leukemia. J Clin Oncol. 2013;31:2065–6.
17. Zhang H, Luo XQ, Zhang P. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One. 2009;4:e7826.
18. Png KJ, Yoshida M, Zhang XH. MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev. 2011;25:226–31.
19. Yan Z, Xiong Y, Xu W. Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS One. 2012;7:e40037.
20. Heyn H, Engelmann M, Schreek S. MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development. Int J Cancer. 2011;129:2797–806.
21. Cao J, Cai J, Huang D. miR-335 Represents an independent prognostic marker in epithelial ovarian cancer. Am J Clin Pathol. 2014;141:437–42.
22. Peng HH, Zhang YD, Gong LS. Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma. Onco Targets Ther. 2013;6:1625–30.
23. Wang Y, Zhao W, Fu Q. miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells. Mol Cell Biochem. 2013;384:105–11.